CRBU - Caribou Bioscience GAAP EPS of -$0.48 beats by $0.01 revenue of $3.76M beats by $0.69M August, 08 2023 05:19 PM Caribou Biosciences Inc. 2023-08-08 17:19:01 ET Caribou Bioscience press release ( NASDAQ: CRBU ): Q2 GAAP EPS of -$0.48 beats by $0.01 . Revenue of $3.76M (-10.3% Y/Y) beats by $0.69M . For further details see: Caribou Bioscience GAAP EPS of -$0.48 beats by $0.01, revenue of $3.76M beats by $0.69M